Balance Sheet for Aduro Biotech Inc. (ADRO)

$ 1.47   -0.02 (-1.34%) Volume: 284.99k 4:00 PM EDT 17-Jul-2019
After Hours:  $ 1.47 0.00 (0.00%) Volume: 2.75k 5:53 PM EDT 17-Jul-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 126,310 157,614 74,932 150,456 119,456
Restrictable Cash - - - - -
Marketable Securities 140,129 168,489 272,500 265,198 -
Accounts Receivable 12,037 989 1,138 4,846 3,153
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 12,037 18,484 1,138 4,846 3,153
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 4,500 5,544 6,194 4,004 2,612
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 282,976 350,131 354,764 424,504 125,221
Land and Improvements - - - - -
Buildings and Improvement 26,961 27,102 17,473 1,367 304
Machinery, Furniture and Equipment 12,133 11,026 8,613 4,276 1,772
Construction in Progress 1,458 54 3,930 - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 40,552 38,182 30,016 5,643 2,076
Gross Fixed Assets 40,552 38,182 30,016 5,643 2,076
Accumulated Depreciation (11,395) (7,097) (3,632) (1,657) (1,023)
Net Fixed Assets 29,157 31,085 26,384 3,986 1,053
Intangibles 25,135 31,107 27,827 29,400 -
Cost in Excess 8,334 8,723 7,658 8,469 -
Non-Current Deferred Income Taxes - 15,649 6,319 - -
Other Non-Current Assets 468 468 1,185 75 188
Total Non-Current Assets 74,528 94,997 83,847 57,321 1,241
Total Assets 357,504 445,128 438,611 481,825 126,462
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 1,457 344 2,206 5,086 5,030
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 7,788 12,745 8,340 8,169 4,482
Accrued Liabilities 7,788 12,745 8,340 8,169 4,482
Deferred Revenues 16,000 14,923 15,052 15,046 33,427
Current Deferred Income Taxes (146) 6,180 (7,800) - -
Other Current Liabilities 5,272 13,389 5,034 2,765 1,276
Total Current Liabilities 30,517 41,401 30,632 31,066 44,215
Long Term Debt - - - - -
Deferred Income Tax 6,104 6,538 5,869 7,350 2,592
Other Non-Current Liabilities 185,572 159,716 174,890 16,823 3,581
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - 164,964 139,963
Total Non-Current Liabilities 191,676 166,254 180,759 189,137 143,544
Total Liabilities 222,193 207,655 211,391 220,203 187,759
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 135,311 237,473 227,220 261,622 (61,297)
Common Par 8 8 7 6 -
Additional Paid in Capital 538,895 519,435 420,897 362,807 346
Cumulative Translation Adjustments - - - - -
Retained Earnings (404,532) (283,863) (192,000) (100,852) (61,643)
Treasury Stock - - - - -
Other Equity Adjustments 940 1,893 (1,684) (339) -
Total Capitalization 135,311 237,473 227,220 261,622 (61,297)
Total Equity 135,311 237,473 227,220 261,622 (61,297)
Total Liabilities & Shareholder's Equity 357,504 445,128 438,611 481,825 126,462
Cash Flow (99,030) (96,470) (95,531) (40,657) (17,014)
Working Capital 252,459 308,730 324,132 393,438 81,006
Free Cash Flow (71,124) (94,010) (109,963) 152,636 18,583
Invested Capital 135,311 237,473 227,220 261,622 (61,297)
Shares Outstanding - Common Class Only 79,572 77,736 67,918 63,588 -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 79,572 77,736 67,918 63,588 57,147
Total Common Shares Outstanding 79,572 77,736 67,918 63,588 -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 78,812 72,901 65,201 44,706 28,043
Diluted Weighted Shares Outstanding 78,812 72,901 65,201 44,706 28,043